Caricamento...
Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds
As multiple myeloma (MM) progresses, natural killer (NK)-cell responses decline against malignant plasma cells. The immunomodulatory drug lenalidomide is widely used for treatment of MM but its influence on NK-cell biology is unclear. Here, we report that lenalidomide lowers the threshold for NK-cel...
Salvato in:
| Pubblicato in: | Blood |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4551357/ https://ncbi.nlm.nih.gov/pubmed/26002964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-01-625004 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|